The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.

Before 2024 ends, Congress will decide whether to keep or change rules about telehealth, or let them expire. And even though the decision will focus on Medicare's payment for virtual patient care, it ...